U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.
about
Galeterone for the treatment of advanced prostate cancer: the evidence to dateImpact of enzalutamide on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectivesEffect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide.Targeting BET bromodomain proteins in solid tumorsMechanisms of Therapeutic Resistance in Prostate Cancer.Novel mechanism-based therapeutics for androgen axis blockade in castration-resistant prostate cancer.Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis.Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expressionTreatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis
P2860
Q26739887-2BB37B75-CD3D-4FE7-BAD9-146587137553Q28076911-8FDF8717-4B38-4DB0-B031-2170F979D1B7Q37082790-4A43FAF2-477D-4886-9FE9-C62714F427C4Q37619860-AB299320-0623-4FD3-9CC3-8E040C83BC5DQ38754316-EDC7B747-9D55-45C3-9D06-53CDD07A64DEQ38775459-2C4A5AC5-7272-46D0-9CC8-F57992989EB2Q48189307-59A2F685-0A5B-4665-85FF-FF6F3179E2B2Q57068289-046558DD-1AF6-475C-8316-89CCAB99F4BDQ58760593-C380B0B2-8DE2-4EFB-B096-DDA0BBFC4888
P2860
U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
U.S. Food and Drug Administrat ...... ion-Resistant Prostate Cancer.
@ast
U.S. Food and Drug Administrat ...... ion-Resistant Prostate Cancer.
@en
type
label
U.S. Food and Drug Administrat ...... ion-Resistant Prostate Cancer.
@ast
U.S. Food and Drug Administrat ...... ion-Resistant Prostate Cancer.
@en
prefLabel
U.S. Food and Drug Administrat ...... ion-Resistant Prostate Cancer.
@ast
U.S. Food and Drug Administrat ...... ion-Resistant Prostate Cancer.
@en
P2093
P2860
P1433
P1476
U.S. Food and Drug Administrat ...... ion-Resistant Prostate Cancer.
@en
P2093
Amna Ibrahim
Geoffrey Kim
Lijun Zhang
Michael Brave
Rajeshwari Sridhara
Richard Pazdur
Shenghui Tang
V Ellen Maher
Yang-Min Ning
P2860
P304
P356
10.1634/THEONCOLOGIST.2015-0166
P577
2015-06-12T00:00:00Z